Last reviewed · How we verify
NCT01996280: CTMI
A Randomized Clinical Trial of Culturally Tailored MI
NA trial testing Motivational Interviewing in Alcohol Drinking in 301 participants. Completed in 30 November 2017.
30 October 2017
Quick facts
| Lead sponsor | Northeastern University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 301 |
| Start date | 26 August 2014 |
| Primary completion | 30 October 2017 |
| Estimated completion | 30 November 2017 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Motivational Interviewing
- Culturally Tailored MI
Conditions studied
- Alcohol Drinking — all drugs for Alcohol Drinking →
Sponsor
Northeastern University
Who can join
Adults 18 to 65, any sex, with Alcohol Drinking. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Culturally-tailored empirically-based interventions are needed because Latinos suffer a greater burden of alcohol-related health disparities and negative social consequences compared to other racial/ethnic groups, are less likely to initiate and to remain in treatment, and are more likely to live in communities with a high density of alcohol outlets. Pilot data from the PI's (New Investigator) K award (AA014905), which will serve as the basis for the current proposed larger-scale study, demonstrated that culturally tailored motivational interviewing (CTMI) outperformed motivational interviewing (MI) that was not tailored to the needs of Latino heavy drinkers. The public health impact of this study will be to develop a program of early screening and brief intervention to reduce hazardous drinking among Latinos, to minimize the burden of illness and social consequences that disproportionately affect Latino communities.
Publications & conference data
5 peer-reviewed publications reference this trial (live from Europe PMC):
-
A randomized controlled trial of motivational interviewing tailored for heavy drinking latinxs.
Lee CS, Colby SM, Rohsenow DJ, Martin R, et al · · 2019 · cited 26× · PMID 31403817 · DOI 10.1037/ccp0000428 -
Acculturation, hazardous drinking and depressive symptomatology among Hispanics enrolled in a clinical trial.
Lee CS, Almeida J, Colby SM, Tavares T, et al · · 2016 · cited 12× · PMID 26819573 · DOI 10.3109/16066359.2015.1072517 -
The role of the relational context and therapists' technical behaviors in brief motivational interviewing sessions for heavy alcohol consumption: Findings from a sample of Latinx adults.
Magill M, Walthers J, Figuereo V, Torres L, et al · · 2023 · cited 3× · PMID 36270197 · DOI 10.1016/j.jsat.2022.108898 -
Technical and relational process in MI sessions with a sample of Hispanic/Latinx adults who engage in heavy drinking: A latent growth mediation model.
Magill M, Figuereo V, Zelaya DG, Jackson K, et al · · 2026 · cited 1× · PMID 38193481 · DOI 10.1080/15332640.2024.2301718 -
Culturally adapted motivational interviewing's effects on drinking in response to immigration and acculturation stressors among Latinx adults with heavy drinking problems.
Hai AH, Lee CS, Zhou C, Delva J. · · 2023 · cited 1× · PMID 37156426 · DOI 10.1016/j.josat.2023.209061
Verify or expand the search:
- PubMed search for NCT01996280
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Motivational Interviewing
Trials testing the same drug.
- NCT07218471 — Cannabis Reduction and Functional Outcomes · NA · recruiting
- NCT07415707 — The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in N · NA · recruiting
- NCT07364773 — Enhancing Rehabilitation Participation in Patients With SCI/D Using Motivational Interviewing · NA · recruiting
- NCT07169955 — The Effect of Motivational Interviewing on Patients With Lumbar Discectomy · NA · completed
- NCT06852664 — Improving Activity in Individuals With Cerebral Palsy · NA · recruiting
Other recruiting trials for Alcohol Drinking
Currently open trials in the same condition.
- NCT07415707 — The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in N · NA · recruiting
- NCT06815237 — Effects of Ketone Supplement and Alcohol on Brain Metabolism · Phase 2, PHASE3 · recruiting
- NCT06994962 — Multi-Component Breath Alcohol Intervention Phase 3 · NA · recruiting
- NCT05363878 — Development of a Culturally Grounded, Trauma-Informed Alcohol Intervention With a Reserve-Dwelling First Nation Group · NA · recruiting
- NCT06309134 — The Healthy Families Bright Futures Program · NA · recruiting
Other Northeastern University trials
Trials by the same sponsor.
- NCT07421830 — An Empowering Parent Training Intervention to Increase Physical Activity in Preschool Aged Children With Autism · NA · recruiting
- NCT07147894 — Executive Function Training for Children and Adolescents · NA · recruiting
- NCT06435819 — ECA-enhanced Document Explanation RCT · NA · recruiting
- NCT07139795 — The Mind-Body Project · NA · active not recruiting
- NCT06645652 — Visual Arts Interventions With Older Adults · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01996280 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Northeastern University
- Last refreshed: 1 April 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01996280.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing